MoonLake Immunotherapeutics

NASDAQ:MLTX

44.89 (USD) • At close January 27, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q4
Omzet 0000.02000000000000
Kosten van de omzet 00.0280.0230.0030.0030.0030.00300.0030000000
Brutowinst 0-0.028-0.0230.016-0.003-0.003-0.0030-0.0030000000
Brutowinstmarge 0000.833000000000000
Onderzoek- en ontwikkelingskosten 35.73623.63412.9918.0957.5858.7047.41511.3699.02411.40110.45512.0980.6729.86700
Algemene en administratieve kosten 7.3766.9166.8066.9315.3924.4825.5165.3275.7466.2525.48712.8945.5982.81500
Verkoop- en marketingkosten 00000000000-10.670000
Verkoop-, algemene en administratieve kosten 7.3766.9166.8066.9315.3924.4825.5165.3275.7466.2525.4872.2245.5982.8150.0940.101
Overige kosten 05.9375.9157.1861.3860.8430.72400.0380.2450.070.007-0.021-0.0040.0180
Bedrijfskosten 43.11230.5519.79815.02612.97713.18612.93216.69614.77117.65215.9422.2246.26732.6820.0940.101
Bedrijfsresultaat -43.112-30.578-19.82-15.029-12.977-13.186-12.932-16.696-14.771-17.652-15.942-2.224-6.267-32.682-0.094-0.101
Bedrijfsresultaat ratio 000-761.419000000000000
Totaal overige inkomsten en kosten netto 7.095.8985.9157.1861.3860.8430.7240.240.0380.2450.07-22.817-0.021-0.0040.0180.015
Inkomen voor belasting -36.022-24.68-13.905-7.843-11.59-12.343-12.208-16.457-14.733-17.407-15.873-2.222-6.288-32.686-0.076-0.086
Inkomen voor belasting ratio 000-397.36000000000000
Belastingkosten 0.0920.0790.070.0440.0290.010.0110.0110.0090.0090.0070.0060-0-0.0550
Nettowinst -35.39-24.267-13.674-7.437-9.426-10.139-12.219-1.935-14.742-17.416-15.88-2.222-6.288-32.686-0.076-0.086
Nettowinstmarge 000-376.79000000000000
WPA (Winst Per Aandeel) -0.56-0.39-0.22-0.12-0.18-0.23-0.31-0.05-0.4-0.49-0.43-0.15-0.17-0.89-0.005-0.006
Verwaterde WPA -0.56-0.39-0.22-0.12-0.18-0.23-0.31-0.05-0.4-0.49-0.43-0.15-0.17-0.89-0.005-0.006
EBITDA -43.079-30.55-19.798-15.026-12.973-13.183-12.928-16.693-14.767-17.649-15.94-2.224-6.265-32.6820-0.086
EBITDA ratio 000-761.252000000000000